AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 152 filers reported holding AERIE PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $367,069 | +148.8% | 24,261 | +23.3% | 0.00% | +200.0% |
| Q2 2022 | $147,525 | -33.2% | 19,670 | -18.9% | 0.00% | 0.0% |
| Q1 2022 | $220,821 | +106.1% | 24,266 | +59.0% | 0.00% | 0.0% |
| Q4 2021 | $107,160 | -38.4% | 15,265 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $174,021 | -28.8% | 15,265 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $244,393 | -10.4% | 15,265 | 0.0% | 0.00% | -33.3% |
| Q1 2021 | $272,786 | +22.8% | 15,265 | -7.1% | 0.00% | +50.0% |
| Q4 2020 | $222,077 | -2.9% | 16,438 | -15.4% | 0.00% | -33.3% |
| Q3 2020 | $228,809 | -20.3% | 19,440 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $286,934 | +9.3% | 19,440 | 0.0% | 0.00% | -25.0% |
| Q1 2020 | $262,440 | -44.1% | 19,440 | 0.0% | 0.00% | -20.0% |
| Q4 2019 | $469,865 | +25.8% | 19,440 | 0.0% | 0.01% | +25.0% |
| Q3 2019 | $373,637 | -35.0% | 19,440 | 0.0% | 0.00% | -33.3% |
| Q2 2019 | $574,450 | -26.2% | 19,440 | +18.6% | 0.01% | -33.3% |
| Q1 2019 | $778,620 | +31.6% | 16,392 | 0.0% | 0.01% | +28.6% |
| Q4 2018 | $591,751 | -41.3% | 16,392 | 0.0% | 0.01% | -36.4% |
| Q3 2018 | $1,008,928 | -8.9% | 16,392 | 0.0% | 0.01% | -15.4% |
| Q2 2018 | $1,107,000 | +33.2% | 16,392 | +7.0% | 0.01% | +30.0% |
| Q1 2018 | $831,000 | -9.3% | 15,326 | 0.0% | 0.01% | 0.0% |
| Q4 2017 | $916,000 | – | 15,326 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|